Cargando…
Gut Microbiota and Inflammatory Cytokine Changes in Patients with Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by sacroiliac joint lesions and spinal ascending involvement. The aim of this work was at investigating the gut microbiota profile and proinflammatory cytokines in AS patients. Gut microbiota of AS patients was clearly diffe...
Autores principales: | Liu, Bin, Ding, Zhenghua, Xiong, Junhui, Heng, Xing, Wang, Huafu, Chu, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417757/ https://www.ncbi.nlm.nih.gov/pubmed/36033581 http://dx.doi.org/10.1155/2022/1005111 |
Ejemplares similares
-
Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021) -
Microbes, the gut and ankylosing spondylitis
por: Costello, Mary-Ellen, et al.
Publicado: (2013) -
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis
por: Dai, Qinghong, et al.
Publicado: (2022) -
Cytokines and regulatory T cells in ankylosing spondylitis
por: Liao, Hsien-Tzung, et al.
Publicado: (2023) -
Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice
por: Liu, Bin, et al.
Publicado: (2019)